Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Net Equity Issued and Repurchased (2018 - 2019)

Updated

Vitaspring Biomedical's Net Equity Issued and Repurchased was $50,000 in FY2022 (year ended Jan 31, 2022), down 39.3% from $82,342 in FY2021.

Analysis

Vitaspring Biomedical (VSBC) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends

From FY2017 onward, Vitaspring Biomedical has reported Net Equity Issued and Repurchased for 4 fiscal years.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 75.5% (FY2017 to FY2022).
  • The FY2022 figure marks the lowest annual Net Equity Issued and Repurchased since FY2019.
  • Per Business Quant data, Net Equity Issued and Repurchased in earlier fiscal years was $82,342 in FY2021 and $18,896 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2019 -3,000.00
Oct 31, 2018 19,075.00
Jul 31, 2018 1,719.00
Apr 30, 2018 1,102.00
API Access

Vitaspring Biomedical Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VSBC&period=max&api_key=YOUR_API_KEY